ArticleMolecular diagnosis & therapy2014

FcγR and EGFR polymorphisms as predictive markers of cetuximab efficacy in metastatic colorectal cancer.

Yuka Inoue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.